SCHEMBL14075266

SCHEMBL14075266

CCCCCCOc1ccc(C(=O)Nc2cc(Cl)ccc2C(=O)O)cc1

nearest known ligand 0.78

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ PLK1 P53350 9/20 0.78
▸ MEN1 O00255 2/20 0.67
▸ KMT2A Q03164 2/20 0.67
▸ PKM P14618 1/20 0.67
▸ NPSR1 Q6W5P4 1/20 0.67
▸ NR1H4 Q96RI1 2/20 0.57
▸ KDM4E B2RXH2 1/20 0.57
▸ ALDH1A1 P00352 1/20 0.57
▸ PLK3 Q9H4B4 1/20 0.55
▸ TP53 P04637 2/20 0.55
▸ TSHR P16473 1/20 0.55
▸ PLA2G4B P0C869 1/20 0.54
▸ NPC1 O15118 1/20 0.53
▸ RAB9A P51151 1/20 0.53
▸ SMN1; SMN2 Q16637 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13941747 0.87 MEN1 (0.75) PLK1MEN1KMT2APKMNPSR1
SCHEMBL14075222 0.83 SERPINE1 (0.67) PLK1MEN1KMT2APKMNPSR1
SCHEMBL14075268 0.83 PLK1 (0.75) PLK1MEN1KMT2APKMNPSR1
SCHEMBL14075264 0.81 PLK1 (0.69) PLK1MEN1KMT2APKMNPSR1
SCHEMBL8027782 0.81 PLK1 (0.93) PLK1MEN1KMT2ANR1H4PLK3
SCHEMBL1308442 0.81 KMT2A (1.00) MEN1KMT2APKMNPSR1KDM4E
SCHEMBL1308714 0.79 MEN1 (0.76) MEN1KMT2APKMNPSR1NR1H4
SCHEMBL6353181 0.79 AKR1C2 (0.77) PLK1MEN1KMT2ANR1H4PLK3
SCHEMBL1307943 0.78 SERPINE1 (0.70) PLK1MEN1KMT2APKMNPSR1
SCHEMBL14075251 0.78 PLK1 (0.72) PLK1NR1H4PLK3TP53TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7429677-B2 Small molecule entry inhibitors TIBOTEC PHARMACEUTICALS LTD. (IE) 2008-09-30 — — US disclosed
US-7429677-B2 Small molecule entry inhibitors TIBOTEC PHARMACEUTICALS LTD. (IE) 2008-09-30 — — US disclosed
Send feedback